OLR1 and metabolic syndrome: Serum sLOX-1 and cLDL levels above the aforementioned cutoff values (Table 3 and Table 4) were significantly associated with a higher risk of MetS (OR 4.75; 95% CI: 1.58–14.25, p = 0.009 and OR 24.28, 95% CI: 5.86–104.61, p < 0.001, respectively).